These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9589046)

  • 1. [Long-term survival in terms of DNA-RNA contents in breast cancer].
    Hara S; Kondo M; Tagawa Y; Itoyanagi N; Kishimoto K; Matuo S; Akamine S; Takahashi T; Oka T; Ayabe H
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():422-5. PubMed ID: 9589046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between DNA ploidy and survival in breast cancer].
    Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():431-5. PubMed ID: 9589048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNA analysis by flow cytometry in breast carcinoma].
    Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
    Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative DNA analysis of breast cancer by flow cytometry and image analysis.
    Borgiani L; Cogorno P; Toso F; Gallo L; Buccaran G; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):356-9. PubMed ID: 7535909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the malignancy in gallbladder cancer assessed by nuclear DNA contents and mitotic indices--with special reference to the prognosis of the patients with cancer involvement to the subserosal layer].
    Sato Y; Tanaka J; Yoshioka H; Koyama K
    Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):46-51. PubMed ID: 2014025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.
    El-Naggar AK; Kemp BL; Sneige N; Hurr KG; Steck K; Tu ZN; Fritsche HA; Singletary SE; Balch CM
    Clin Cancer Res; 1996 Feb; 2(2):419-26. PubMed ID: 9816186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA index as prognostic factor in breast cancer.
    Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
    Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of cellular DNA and RNA contents of hydatidiform mole. Two significant parameters indicating malignant nature and prognosis.
    Yin GP; Su YK
    Chin Med J (Engl); 1993 Feb; 106(2):136-40. PubMed ID: 8389273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].
    Kimijima I; Katagata N; Tsuchiya A; Takenoshita S
    Nihon Rinsho; 2000 Apr; 58 Suppl():401-6. PubMed ID: 11026024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative analysis of the cellular DNA and RNA contents of hydatidiform mole and its clinical significance].
    Yin GP; Su YK; Zhuang GX
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):538-41, 574. PubMed ID: 7835131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
    Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
    Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoploidy defines patients with poor prognosis in breast cancer.
    Chavez-Uribe E; Cameselle-Teijeiro J; Viñuela JE; Castro-Piñeiro C; Gude F; Forteza J; Puente-Domínguez JL
    Oncol Rep; 2007 May; 17(5):1109-14. PubMed ID: 17390052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
    Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Gruchała A; Jaszcz-Gruchała A
    Pol J Pathol; 2003; 54(2):101-10. PubMed ID: 14575418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
    Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.